ClinicalTrials.gg
RecruitingNCT06705907Updated Oct 20, 2026

Improving Academic and Social Functioning in Middle-Schoolers With Autism

An interventional study of Achieving Independence and Mastery in School (AIMS) and Building Essential Social Skills for Teens (BESST) in Autism and Autism Spectrum Disorder, sponsored by Children's Hospital Medical Center, Cincinnati. Recruiting at 1 site in United States. Open to participants aged 10 Years to 15 Years. Per ClinicalTrials.gov, last updated 2026-10-20.

Sponsored by Children's Hospital Medical Center, Cincinnati · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Dec 2024; still recruiting 1 year 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
224
Allocation
Randomized
Ages
10 Years to 15 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 12 studies in Autistic Disorder by Children's Hospital Medical Center, Cincinnati — 2 open to participants now, 2 under way, none of them phase 3. Autistic Disorder · Children's Hospital Medical Center, Cincinnati.

Planned enrollment
Largest of 10
224 · median 77
Started
2024
with 1 other
No phase
5 of 12
2 open now
Registered
12th of 12
by date

Among the 12 studies in Autistic Disorder by Children's Hospital Medical Center, Cincinnati, this one has the largest planned enrollment of the 10 interventional ones that give a count, is one of 2 that started in 2024, is one of 5 with no phase, and was the 12th registered.

Autistic Disorder

1,035 studies on the registry are indexed under Autistic Disorder; 270 are open to participants now.

Browse Autistic Disorder studies →

Open to participants now

2 of the 12 studies in Autistic Disorder by Children's Hospital Medical Center, Cincinnati are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Where they have run

Who these studies take

Of the 184 Autistic Disorder studies recruiting now, 33 (18%) set no upper age limit and 144 (78%) stop at 75 or younger; 150 take children under 18; 56 take healthy volunteers.

This study: 10 Years to 15 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Autistic Disorder by Children's Hospital Medical Center, Cincinnati, or all of them as a file.
02

Study summary

The goal of this study is to test how well two group interventions work for middle-school children with Autism Spectrum Disorder (ASD). One of the interventions focuses on teaching parents and adolescent skills to help improve their social functioning and the other focuses on teaching parents and adolescents skills to improve organization, planning, and study skills. Eligible participants will be randomly (like a coin flip) assigned to attend one of the two interventions.

03

Conditions studied

  • Autism
  • Autism Spectrum Disorder

Keywords

  • social skills
  • executive functions
  • academic achievement
  • middle school
04

Who can participate

Ages eligible
10 Years to 15 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of autism
  • No intellectual disability
  • Problems with organization, materials management, and planning and prioritization
  • Problems with social skills
  • Fully included in middle school
  • Stable medication and behavioral treatment regime

Exclusion criteria

Exclusion Criteria:

  • Home schooled
  • Severe co-occurring psychopathology (e.g., aggression, suicidal)
  • Non English-speaking
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
224 participants (estimated)

Study arms

  • Experimental
    Achieving Independence & Mastery in School (AIMS)

    AIMS targets executive functioning skills using evidence-based strategies for youth with ASD to promote increased independence related to academics. Each session involves a review of a real world practice assignment and a didactic component illustrating key concepts followed by an in-session practice of the key concepts and strategies with coaching from a therapist. A behavior agreement is used to identify specific goals for adolescents to work on in collaboration with their caregivers and specific rewards earned for meeting their goals. Adolescents are assigned a real world practice assignment each session that consists of additional practice of strategies to further build and generalize skills between sessions.

    Behavioral: Achieving Independence and Mastery in School (AIMS)

  • Active comparator
    Building Essential Social Skills for Teens (BESST)

    BESST targets social skills using evidence-based strategies and includes sessions related to starting, joining, maintaining, and ending conversations and making, maintaining, and deepening friendships. Each skill will be introduced in a didactic lesson which includes modeling of the targeted skill by a therapist. Adolescents will role-play new skills during the session before receiving a homework assignment to practice the skill at home. Caregivers will receive training in social-communication difficulties in ASD and suggestions for supporting development of these skills. The sessions are specifically focused on generalizing newly learned skills to both home and school.

    Behavioral: Building Essential Social Skills for Teens (BESST)

Interventions

  • BehavioralAchieving Independence and Mastery in School (AIMS)

    Intervention targeting academic executive functioning

    Also known as: AIMS

  • BehavioralBuilding Essential Social Skills for Teens (BESST)

    Intervention targeting social skills

    Also known as: BESST

06

What researchers measure

Primary outcomes

  1. Behavior Rating Inventory of Executive Functioning, 2nd Edition

    The BRIEF-2 assesses real-world EF behaviors in the home and school environments. The T-scores range from 30:99 with higher scores being worse.

    Time frame: From enrollment to the end of treatment at 8 weeks.

  2. Homework Problems Checklist

    The HPC assesses Homework Completion and Homework Management. Scores for Homework Completion range from 0 to 36 and for Homework Management from 0 to 21. Lower scores are better.

    Time frame: From enrollment to end of treatment at 8 weeks.

  3. Academic Performance Rating Scale

    The teacher-completed APRS assesses how well the adolescent is performing academically with 3 subscales (Academic Success, Academic Productivity, and Impulse Control). The two scores to be used in the current study include the Academic Success score which ranges from 7 to 35, while the Academic Productivity score ranges from 12 to 60. Higher scores are better.

    Time frame: From enrollment to end of treatment at 8 weeks.

Secondary outcomes

  1. Children's Organizational Skills Scale

    The COSS is a psychometrically strong rating scale assessing Organized Actions, Task Planning, and Memory \& Materials Management. The T scores for each subscale range from 20 to 83 and higher scores indicate worse functioning.

    Time frame: From enrollment to the end of treatment at 8 weeks.

  2. Weekly Calendar Planning Activity

    The WCPA is an objective measure of metacognition (i.e., planning, inhibition, problem solving, keeping track of rules, and monitoring passage of time) while performing a multiple-step activity (i.e., scheduling multiple appointments while adhering to various rules). The WCPA will report total appointments entered (0 to 10) and total correct appointments entered (0 to 10) with higher values being better.

    Time frame: From enrollment to the end of treatment at 8 weeks.

  3. Social Skills Assessment (TRIAD)

    The TRIAD assesses social skills (i.e., emotion understanding and perspective taking, initiating and ending interactions, responding to others, maintaining interactions and problem solving, and following social rules) rated on a 1 to 4 scale (1=not very well to 4=very well). Items rated 2 or less are considered areas of weakness. Items rated as 3 or above are considered areas of strength.

    Time frame: From enrollment to the end of treatment at 8 weeks.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — All collected IPD will be entered into NIMH's Data Archive (NDA) in order to contribute to the advancement of research on individuals with ASD. In our Background History Form, we will collect the prerequisite information (i.e., specific information such as legal name, date of birth, sex, and city of birth) needed to generate a GUID. Informed consent documents will inform participants that their data will be entered into NDA.

Supporting information: Study protocol, Informed consent form

Time frame: August 31, 2029

Access criteria: Investigators interested in using the data obtained in this study will be directed to obtain the data from NDA. Other materials can be obtained from the study principal investigators upon reasonable request.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2024 (actual). Primary completion is estimated for May 2029, 53 months after the start.

Of 355 non-industry interventional studies with no phase under Autistic Disorder, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 50. This study's planned 53 months is above that.

Counting every sponsor, half of 367 studies reached it within 26 months; a quarter within 13 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 23, 2024
First posted
Nov 26, 2024
StartActual
Dec 1, 2024
Primary completionEst.
May 31, 2029
CompletionEst.
Aug 31, 2029
Last update
Oct 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Site contacts
Changed at 1 site. See the sites
Show the site
  • Cincinnati Children's Hospital · Cincinnati, United StatesContact s•••@cchmc.org · •••5994→s•••@cchmc.org · •••5995
Oct 20, 2026
Show all 1 update
  1. Oct 20, 2026
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Cincinnati Children's Hospital · Cincinnati, United StatesContact s•••@cchmc.org · •••5994→s•••@cchmc.org · •••5995
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06705907
Responsible party
Sponsor
First posted
Nov 26, 2024
Start date
Dec 1, 2024
Primary completion
May 31, 2029 (estimated)
Completion
Aug 31, 2029 (estimated)
Last update
Oct 20, 2026

Study contacts

Leanne Tamm, Ph.D.
Contact
leanne.tamm@cchmc.org
513-803-3176
Amie Duncan, Ph.D.
Contact
amie.duncan@cchmc.org
513-803-2416
Leanne Tamm, Ph.D.
principal investigator · Children's Hospital Medical Center, Cincinnati
Amie Duncan, Ph.D.
principal investigator · Children's Hospital Medical Center, Cincinnati

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion